نتائج البحث

Correspondence to "Effectiveness and safety of generic tofacitinib in spondyloarthritis: A real-world retrospective analysis from India".

• Authors : Chen SY; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Lin TA

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Spondylarthritis*/Spondylarthritis*/Spondylarthritis*/diagnosis

• Source: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Dec; Vol. 26 (12), pp. 2587-2588. Date of Electronic Publication: 2023 Jun 28.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

تفاصيل العنوان

Tofacitinib versus methotrexate as the first-line disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: An open-label randomized controlled trial.

• Authors : Khan MM; Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.; Department of Rheumatology, Mymensingh Medical College Hospital, Mymensingh, Bangladesh.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

• Source: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Sep; Vol. 26 (9), pp. 1729-1736. Date of Electronic Publication: 2023 Jun 28.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

تفاصيل العنوان

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.

• Authors : Riek M; SCQM Foundation, Aargauerstrasse 250, 8048, Zurich, Switzerland. .; Scherer A

Subjects: Biological Products*/Biological Products*/Biological Products*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/epidemiology ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects

• Source: Scientific reports [Sci Rep] 2023 Oct 18; Vol. 13 (1), pp. 17776. Date of Electronic Publication: 2023 Oct 18.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

A case series on tofacitinib-induced weight gain.

• Authors : Shah K; Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.; Shukla D

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Drug-Related Side Effects and Adverse Reactions*

• Source: Indian journal of pharmacology [Indian J Pharmacol] 2023 Jul-Aug; Vol. 55 (4), pp. 263-265.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print Cited Medium: Internet ISSN: 1998-3751

تفاصيل العنوان

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

• Source: XELJANZ (REGISTERED) TABLETS 5MG SPECIAL INVESTIGATION (ALL-CASES SURVEILLANCE)

تفاصيل العنوان

Beneficial Effect of Upadacitinib in an Adult Patient with Juvenile Idiopathic Arthritis-associated Uveitis after Unsatisfactory Response to Tofacitinib: A Case Report.

• Authors : Baquet-Walscheid K; Department of Ophthalmology, St. Franziskus Hospital, Muenster, Germany.; Department of Ophthalmology, University of Duisburg-Essen, Essen, Germany.

Subjects: Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/complications ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/diagnosis ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy

• Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2023 Jul; Vol. 31 (5), pp. 1079-1080. Date of Electronic Publication: 2022 May 19.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Effectiveness and safety of generic tofacitinib in spondyloarthritis: A real-world retrospective analysis from India.

• Authors : Phatak S; K.E.M. Hospital Research Centre, Pune, India.; B.J. Medical College and Sassoon General Hospital, Pune, India.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/drug therapy ; COVID-19*

• Source: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Mar; Vol. 26 (3), pp. 487-492. Date of Electronic Publication: 2023 Jan 20.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

تفاصيل العنوان

Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study.

• Authors : Haraoui, Boulos¹ (AUTHOR); Khraishi, Majed² (AUTHOR); Choquette, Denis¹ (AUTHOR)

• Source: Rheumatology & Therapy. Dec2024, Vol. 11 Issue 6, p1629-1648. 20p.

تفاصيل العنوان

Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study.

• Authors : Song YJ; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/epidemiology ; Herpes Zoster*/Herpes Zoster*/Herpes Zoster*/chemically induced

• Source: Scientific reports [Sci Rep] 2023 May 15; Vol. 13 (1), pp. 7877. Date of Electronic Publication: 2023 May 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Letter: tofacitinib in the real world - do clinical trial data stand up?

• Authors : Gilmore R; Department of Gastroenterology, St Vincent's Hospital, Melbourne, Australia.; Tassone D

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy; Humans

• Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 745-746.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036

تفاصيل العنوان